Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.

about

Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry.

Item

http://www.wikidata.org/entity/Q47624401

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@en

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@nl

type

Item

label

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@en

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@nl

prefLabel

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@en

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@nl

P1476

Evaluation of Cholinergic Defi ...... 's Disease Using Pupillometry.

@en

P2093

Christopher C Rowe

http://www.w3.org/2001/XMLSchema#string

David Ames

http://www.w3.org/2001/XMLSchema#string

Kevin Taddei

http://www.w3.org/2001/XMLSchema#string

Liam Robinson

http://www.w3.org/2001/XMLSchema#string

Ralph N Martins

http://www.w3.org/2001/XMLSchema#string

Shaun Frost

http://www.w3.org/2001/XMLSchema#string

Stephanie R Rainey-Smith

http://www.w3.org/2001/XMLSchema#string

Yogesan Kanagasingam

http://www.w3.org/2001/XMLSchema#string

P2860

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Mild cognitive impairment: clinical characterization and outcome

The role of biomarkers in clinical trials for Alzheimer disease

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

Altered pupillary size and darkness and light reflexes in Alzheimer's disease

Neuropathologic alterations in mild cognitive impairment: a review

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

P304

7935406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/7935406

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28894607

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5574262

http://www.w3.org/2001/XMLSchema#string